Background: Pediatric heart transplant (PedHtx) patients have increased cardiovas-
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Telehealth is regarded as an emerging tool to deliver care, removing many of the barriers such as transportation difficulties and missing school or work obligations. 6 Patients can engage in the intervention in the comfort of their own home and as their schedule permits. 7 Some pediatric studies have used live-teleconferencing to deliver health and behavior modifications in patients with diabetes and obesity. 8, 9 In a pilot study, we have demonstrated excellent adherence of obese and overweight youth to a live video diet and exercise intervention with significant improvement in their cardiovascular risk profile.
9
The goal of the current study is to evaluate the adherence of pediatric heart transplant patients to a diet and exercise intervention delivered via live video conferencing and to assess the impact of the intervention on measures of cardiac, vascular, and functional health.
Our hypothesis is that participants will attend >80% of the diet and exercise sessions. The methodology and baseline cardiac, vascular, and functional health assessment of the currently enrolled patients are reported in this manuscript.
| ME THODS

| Patient eligibility
Subjects are eligible to participate in the study if they are 8-19 years old at the time of the first study visit, had their transplant 1 year prior to study entry, are able to fast overnight, have cardiac clearance by their primary cardiologist, and can have an adult at home during the exercise training sessions for patients <14 years of age.
Exclusion criteria include rejection within 3 months of the first study visit, allergy to latex, acute illness, or history of multi-organ transplant.
| Recruitment
Pediatric heart transplant patients followed at our center (Lucile Packard Children's Hospital, Stanford) are recruited during clinic visits or through recruitment packages sent via mail. Patients 18-19 years old at the time of study start sign consent forms while patients 8-17 years old sign assent forms with their parents consenting prior to beginning the intervention. The study protocol and all forms are approved by the Stanford Institutional Review Board.
| Study visits
After enrollment, patients are scheduled to come in for a baseline study visit. Participants are asked to fast for 12 hours overnight. Water and regular prescription medications are continued.
Each participant's height, weight, blood pressure, waist and hip F I G U R E 1 Barriers to a heart-healthy lifestyle in pediatric heart transplant patients measurements, and medical history are collected. Participants then undergo various testing protocols as follows:
| Study testing components
The study testing protocol is outlined in Figure 2 .
| Vascular testing
All vascular testing is performed while the patients are fasting.
Carotid artery ultrasound and measurements
Carotid ultrasound is commonly accepted as a non-invasive, safe, inexpensive, and reliable method to image the carotid arteries and to measure the carotid intima-media thickness (CIMT). There is a strong correlation between increased CIMT and coronary heart disease 10, 11 and several conventional cardiovascular risk factors and events are associated with CIMT and stiffness. [12] [13] [14] A linear array probe (L11-3 MHz;
Philips iE33 Ultrasound System, Andover, MA) is used to obtain three 10-second loops taken at anterior, posterior, and lateral angles on the right and left common carotid artery (CCA). We do not use a Meijer's F I G U R E 2 Study overview arc, which is a tool used to standardize angles of insonation for carotid ultrasound studies and therefore referred to these angles as anterior, posterior, and lateral angulations. However, these angles would correspond to approximately 60°, 105°, and 150° for the right and 300°, 255°, and 210° for the left common carotid artery on the arc. The images are stored as DICOM loops. The resolution is 1024 × 768 pixels/ cm. In general, gain and compression adjustments are made on default vascular settings (P mode, no harmonics) to optimize the images. The frame rate is kept at above 50 frames per second and persistence at low setting. The CIMT of the far wall of the CCA is measured online by the sonographer using a frame from each of the loops with anterior, posterior, and lateral angulations over the length of a 1 cm segment located at the distal aspect of the right and left CCA just proximal to the bifurcation into the internal and external carotid arteries, using commercially available, semi-automated edge detection software (QLab Philips, iE33, Andover, MA) at end-diastole on the R wave The measurements are accepted only if the edge detection software is able to automatically measure 95% or more of the 1 cm segment ( Figure 3 ). Cross-sectional dimensions of the common carotid arteries are measured in triplicate and averaged to calculate the arterial pressure-strain elastic modules and stiffness index. The entire EndoPAT test is administered for a total of 20 minutes under standardized conditions of dimmed lights and a silent atmosphere. The initial 5 minutes are for baseline measurements.
In the next 5 minutes, the non-dominant arm is occluded at a range between 180 and 220 mm Hg using a manual blood pressure cuff. After 5 minutes of occlusion, the blood pressure cuff is released and measurements are taken for the remaining 10 minutes. 16 Endothelial functional testing by EndoPAT has been validated in adults as well as used and studied extensively in pediatric groups. 16, 17 All data analysis is conducted through the machine's software package and given as the reactive hyperemia index (RHI).
Lower RHI values indicate impaired endothelial function, with the threshold value of 1.9 defined as normal for children and adolescents based on prior publications 16 ( Figure 4 ). Baseline pulse amplitude is measured from each fingertip for 5 minutes prior to inflation of the cuff and is shown to be directly related to cardiovascular risk factors such as systolic blood pressure, body mass index, and ratio of total to high-density lipoprotein cholesterol. children. 15 The subject's weight, height, and average resting blood pressures are used as inputs in the testing.
Pulse wave velocity Two measurements are made at the visit including the distance from the carotid artery pulse to the sternal notch and the distance from the femoral artery pulse to the sternal notch. The pressure tonometer that resembles a pen-like probe is placed on the carotid artery to capture arterial wave forms gated to the R wave. After successful capture, the probe is placed on the femoral artery to obtain the same waveforms. PWV is calculated by the software using the relative difference in path length between the two arterial sites divided by the difference in F I G U R E 5 Pulse wave analysis (pulse wave velocity and augmentation index) F I G U R E 6 Functional movement screening transit time. Arterial waveforms are captured over a 10-second interval, and each PWV measurement was reported as mean ± SE by the software. 15 This cycle of measurements is completed three times; an average is taken to process the subject's PWV.
Augmentation index The pressure tonometer is applied to the subject's right radial artery to capture arterial pressure waves which are subsequently processed by the software to calculate and reconstruct the central aortic pressure curve. AIx measurements are computed as the ratio (%) of the aortic augmentation to the pulse pressure. The software has an incorporated operator index calculation for AIx measurements where ≥80 is considered optimal based on the waveform variation. The software also calculates the AIx adjusted to a heart rate of 75 beats per min (bpm; AIx75). 15 A total of three optimal (≥80) measurements are captured then averaged to determine the subject's Aix. 15 Increased values of PWV or augmentation index indicate stiffer arteries.
| Blood work
Upon completion of the vascular testing, each participant has blood work to measure their lipid profile, fasting glucose, C-reactive protein, and hemoglobin A1c levels at Stanford Health Care's Clinical Laboratories.
| Fitness testing
Functional movement screening (FMS) and cardiopulmonary exercise stress test are conducted by a certified exercise physiologist. 
Cardiopulmonary exercise stress test
The cardiopulmonary exercise stress test is performed on a programmable cycle ergometer (Corival; Lode, Groningen, the Netherlands) and tested for maximum volume of oxygen consumed (VO 2 max).
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The subjects undergo progressive cardiopulmonary exercise testing with continuous monitoring by 12-lead EKG and gas exchange by measuring breath-to-breath ventilation. Peak oxygen consumption is taken as the maximum VO 2 value obtained during the test. Percentpredicted VO 2 max is calculated, with >70% of percent predicated defined as normal.
Functional movement screening
Functional movement screening is a screening instrument, which evaluates selective fundamental movement patterns to determine potential injury risk. FMS assesses seven basic movements including push-ups, leg lowers, squats, and lunges for any limitations.
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Scoring is on a 0-3 scale for each movement with 0 being the lowestability and 3 as full range of movement ability ( Figure 6 ). Participants fall in an "at risk" category if they score <14 with a total score of 21.
| Child Health Questionnaire
Upon completion of all testing, participants are asked to complete the Child Health Questionnaire, a validated pediatric quality of life survey designed for children aged 5-18 that measures 14 unique physical and psychosocial concepts. 22 Parents are also asked to complete the parent version of the survey. 22 The survey is on a 100-point scale, where higher scores reflect better physical and psychosocial functioning.
23
With the exception of change in health, all categories are evaluated on a scale of 0-100, with 100 being the highest score possible.
| Dietary recall
The patients are walked through the Automated Self-Administered a Five patients "at risk for injury" at total FMS score ≤14. the participant to recall the past 24 hours of food intake. Participants enter all foods consumed the day prior to the study visit with complete descriptions of all foods and drinks. 24 Study participants are asked to complete ASA24 on their own at home twice more during the week following the study visit. They are instructed to choose to complete recalls for one additional weekday and one weekend day.
Results of the 3 days are averaged for each study visit.
| Study education
Once all testing, surveys, and dietary recalls are complete, patients are given the study equipment with thorough explanation of how to use each including the study binder, heart rate monitor, tablet, exercise equipment, and accelerometer. Patient incentive includes parking for all study visits, a 10-dollar cafeteria voucher, the iPad, and all exercise equipment. All log-in information, including for Gmail, ASA24, and Supertracker accounts are written in a binder for the participants to take home, and scheduling expectations are explained.
| Physical activity
After the study visit, patients are instructed to wear an accelerometer for 7 days and to send back the device to the study team via a prepaid label. TA B L E 7 Baseline pulse wave analysis and EndoPAT index 
| Intervention
The intervention was designed accordingly to our patient popula- 
| Diet intervention
First, all participants have a one-hour session with a trained nutrition counselor to learn about the Dietary Approaches to Stop Hypertension (DASH) dietary plan and to review the DASH manual, which provides informational sheets on serving recommendations, foods, and recipe suggestions compliant with the DASH dietary pattern. DASH used in this intervention is modified from the original version (adult) for adolescents. 28 Participants are asked to log nutrition data in Supertracker at least three times a week for the research team to review. Goals are set weekly for fruits (up to 5 a day), vegetables (up to 5 a day), and dairy (up to 3 a day) servings during the 30-minute nutrition session ( Figure 7 ). Lowering the servings of foods that are high in sodium and fat is also encouraged. Each goal has a corresponding implementable plan to reach those goals.
| Exercise intervention
The Participants who call prior to the session are allowed to reschedule within the week.
| Maintenance
The maintenance phase is designed to test for the adherence of the exercise and nutrition practices with less frequent contact with the intervention team. After the initial 12-to 16-week intervention and post-intervention study visit, patients meet with their trainer and nutrition counselor only once a week, with instructions to continue exercising on their own at least twice more using the knowledge they learned during the intervention phase. Nine patients abnormal at <77.
TA B L E 9 24-h dietary recall
b
Eight patients abnormal at <75. 
| Statistical methods
| Exercise and nutrition session adherence
Sessions that are scheduled with a no-show by the patients are recorded as non-attendance. Missed sessions due to routine clinical care (such as biopsy or unavailability due to driving/travel day)
are not recorded as non-attendance and are instead considered not scheduled. Adherence is calculated as the number of sessions attended versus the number of sessions scheduled.
| Sample size calculation
The primary outcome will be adherence rate (ratio of live video exercise and diet sessions attended out of sessions offered). The study with the target sample size of 15 (after attrition) is powered at 80% to detect a difference between a 50% (historical) and 80% adherence rate (1-sample binomial test).
| Baseline results on the enrolled patients
| Patients
Baseline demographic and anthropometric results are summarized below in Table 1 . Thirteen participants (eight females) completed baseline assessment. These patients were at a median of 15.2 [2.3] years of age and 4.8 [8.6 ] years post-heart transplant. One subject (8%) had reported history of seizures. One other subject (8%) had a heart re-transplant 9 years after the first heart transplant, and 2 years prior to enrollment. No other significant medical history was reported. Twelve patients were on calcium-channel blockers, six patients were on statins, and all patients were on immunosuppressive transplant medications as percenter protocol. Three patients had systolic blood pressures >85th percentile for age and height (Table 2 ).
| Cardiopulmonary fitness
As summarized in Table 3 (Table 4) . 30, 31 Accelerometer data over the course of 7 days
showed that these patients spent a median of 67. (Table 5 ). Table 6 .
| Blood work results
Median
| Vascular testing
Endothelial (Table 7) . 
| Diet
Dietary recall results are summarized in Table 9 
| Child Health Questionnaire-Child and parent versions
Child Health Questionnaire-Child results are summarized in Table 10 . 
| Preliminary intervention results
Preliminary results are outlined for the first four patients who completed the intervention in 
| D ISCUSS I ON
Despite improved early survival, long-term survival of pediatric heart transplant patients remains low, with only 50% of pediatric heart transplant patients or grafts surviving more than 15 years after transplant. 1 Cardiac allograft vasculopathy, an accelerated form of coronary artery disease, is a major cause of late mortality. While our study included patients ages 8-19, we do believe that this intervention could also be successful in an even younger pediatric population. The study design would require more overall parental and study team involvement for weekly intervention scheduling and
implementation.
Prior studies have demonstrated similar results. Most pediatric heart transplant patients do not exercise regularly or follow a healthy diet. 33, 34 Overall exercise performance remains reduced in both adult and pediatric heart transplant patients compared to healthy controls. 33, [35] [36] [37] A recent study in pediatric heart transplant patients demonstrated a longitudinal decrease of 1.9 min/d of moderate to vigorous physical activity post-transplant. 38 Management of nutritional issues is vitally important for the prognosis of heart transplant patients. Obesity and diabetes are found with increased prevalence in this population. 39, 40 An adult study demonstrated a mean of 10.1 kg weight gain in the first year post-transplant and reported younger age at the time of transplant to be the only independent predictor of weight gain. Another study in adults showed that patients who were underweight or obese at 1-year post-transplant were at greater risk for graft rejection than patients who were normal weight or overweight. 41 Pediatric heart transplant patients fall into the Tier I category (highest cardiovascular risk category) according to the American
Heart Association Expert Panel on Population and Prevention
Science Statement and are at risk for subclinical atherosclerosis. 2, 3 Hence, these patients are recommended to receive nutrition evaluation and education, activity counseling, and a weight loss program based on their body mass index percentile. 3 The majority of these patients are placed on anti-hypertensive and cholesterol-lowering medications. 3 However, exercise and diet programs are not standard of care in pediatric heart transplant programs and promoting a heart-healthy lifestyle is not often a program priority. 42 Recent guidelines recommend a minimum of 25 hours of faceto-face contact over 6 months for an effective pediatric lifestyle intervention. 43 Yet, there are multiple barriers that children and their families face when they attempt to participate in lifestyle interventions, resulting in low adherence rates (<50%). 4, 44 The most common obstacles are the inability of caregivers to miss work (64%), transportation difficulties (59%), and children having to miss school (55%). 4 Distance to the clinic site is even more of a challenge in patients receiving care in specialized academic centers and can result in worse medical outcomes. 5 Indeed, in our own
center, approximately half of the patients live beyond a 100-mile radius of the institution making their clinical visits a significant burden for the patients and families. A recent exercise intervention study in pediatric heart transplant patients illustrates several of these barriers to delivery of preventive care: endurance time and peak oxygen consumption increased significantly among participants of a 12-week self-directed home exercise program with monthly check-ins in this study. However, only 15 out of the 41 (36%) eligible patients were able to participate in the program. the development and evaluation of strategies for long-term maintenance after intervention as a key priority for research in the field. 47 In conclusion, this baseline manuscript aims to add to the limited literature on the implications of designing and implementing a lifestyle intervention in pediatric heart transplant patients. 
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